. . . "Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients"@nl . . . . . . . "article scientifique publi\u00E9 en 2015"@fr . . . "1052854446" . . . . . . . . . . . . "26063409" . . "im Juni 2015 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . "10.1007/S13277-015-3533-9" . "36" . . "11" . "2015-06-11T00:00:00Z"^^ . . . . "Ke-jun Liu" . . . "Guo-lin Hu" . "Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients"@en . . . . . . . . . . . "8831-8837" . . "Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients"@en . . . . . . . . . . . . . . . "Wei-jiang Liang" . . . . . . . . . . . . "Wei-wei Zhang" . . "Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients"@nl . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en xunu de 2015"@ast . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0447\u0435\u0440\u0432\u043D\u0456 2015"@uk . . . . . . . . . . . . . . . . . "Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients"@en . . . . "Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients"@en . . . . . . . . . . . . "wetenschappelijk artikel"@nl . . "scientific article published on 11 June 2015"@en . . . "Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients"@nl . "2015 \u0569\u057E\u0561\u056F\u0561\u0576\u056B \u0570\u0578\u0582\u0576\u056B\u057D\u056B 11-\u056B\u0576 \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u057E\u0561\u056E \u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0570\u0578\u0564\u057E\u0561\u056E"@hy . .